A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Migraine
Interventions
DRUG

Rimegepant

NURTEC ODT 75 mg orally disintegrating tablets

DRUG

Rizatriptan Benzoate

Rizatriptan ODT 10mg orally disintegrating tablets

Trial Locations (1)

11219

RECRUITING

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER